The FDA decision is expected in mid-2026
While Novo Nordisk and Lilly seem best positioned now, emerging agents, oral options, dual/triple agonist molecules may capture niches or even displace certain uses of the first wave of GLP-1s
Appropriate laboratory testing and medical evaluation are necessary before treatment is considered
Saba GLP-1 is designed to provide consistent support for daily vitality and wellness, helping you feel more energized and focused throughout the day
Tendon Fibroblast Outgrowth Chang et al., Journal of Applied Physiology (2011) Chang and colleagues conducted an in vitro study using tendon fibroblasts isolated from the Achilles tendons of male Sprague-Dawley rats
Amraoui W, Adjabi N, Bououza F, Boumendjel M, Taibi F, Boumendjel A, Abdennour C, Messarah M